Benjamin Perry

1.5k total citations
18 papers, 489 citations indexed

About

Benjamin Perry is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Benjamin Perry has authored 18 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Epidemiology. Recurrent topics in Benjamin Perry's work include Computational Drug Discovery Methods (4 papers), Chemical Synthesis and Analysis (3 papers) and Research on Leishmaniasis Studies (3 papers). Benjamin Perry is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Chemical Synthesis and Analysis (3 papers) and Research on Leishmaniasis Studies (3 papers). Benjamin Perry collaborates with scholars based in United Kingdom, Switzerland and Belgium. Benjamin Perry's co-authors include David M. Parry, Colin R. Groom, William R. Pitt, D. Christopher Braddock, Kirandeep Samby, Alpha A. Lee, Matthew H. Todd, Annette von Delft, Annelies Verbon and Mark Calmiano and has published in prestigious journals such as Nature, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Benjamin Perry

16 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Perry United Kingdom 9 343 156 74 42 39 18 489
S. Murugavel India 13 395 1.2× 105 0.7× 64 0.9× 78 1.9× 47 1.2× 73 578
Asier Gómez‐SanJuan Spain 10 230 0.7× 123 0.8× 51 0.7× 38 0.9× 24 0.6× 13 369
Leandro Cotos Spain 13 347 1.0× 142 0.9× 93 1.3× 35 0.8× 68 1.7× 18 512
Parameshwar Makam India 12 459 1.3× 126 0.8× 56 0.8× 26 0.6× 23 0.6× 21 577
Katja Ester Croatia 14 444 1.3× 192 1.2× 37 0.5× 27 0.6× 18 0.5× 27 685
Gagan Kukreja India 12 401 1.2× 150 1.0× 42 0.6× 45 1.1× 33 0.8× 16 555
Guilherme R. Oliveira Brazil 14 354 1.0× 82 0.5× 34 0.5× 74 1.8× 64 1.6× 31 559
Setshaba D. Khanye South Africa 16 474 1.4× 207 1.3× 53 0.7× 57 1.4× 29 0.7× 45 656
Neelima Sinha India 10 516 1.5× 127 0.8× 38 0.5× 25 0.6× 22 0.6× 19 592
Jonathan Shearer United Kingdom 8 232 0.7× 203 1.3× 25 0.3× 27 0.6× 22 0.6× 10 473

Countries citing papers authored by Benjamin Perry

Since Specialization
Citations

This map shows the geographic impact of Benjamin Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Perry more than expected).

Fields of papers citing papers by Benjamin Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Perry. The network helps show where Benjamin Perry may publish in the future.

Co-authorship network of co-authors of Benjamin Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Perry. A scholar is included among the top collaborators of Benjamin Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Perry. Benjamin Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Khan, Sadiya S., Sana Sheikh, Adeel Khoja, et al.. (2025). Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know?. Current Atherosclerosis Reports. 27(1). 73–73.
2.
Perry, Benjamin, et al.. (2024). N‐Pyrazolyl‐ and N‐Triazolylamines and ‐Ureas as Antileishmanial and Antitrypanosomal Drugs. ChemMedChem. 19(15). e202400220–e202400220. 1 indexed citations
3.
Perry, Benjamin, et al.. (2024). Late‐Stage Diversification of Pyrazoles as Antileishmanial Agents. ChemMedChem. 19(8). e202400028–e202400028. 4 indexed citations
4.
Dichiara, Maria, Hitesh B. Jalani, Edwin G. Tse, et al.. (2023). Structure–Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis. ACS Infectious Diseases. 9(8). 1470–1487. 1 indexed citations
5.
Lim, Wilson, Kimberly Eadie, Ahmed Hassan Fahal, et al.. (2022). Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma. PLoS neglected tropical diseases. 16(2). e0010159–e0010159. 29 indexed citations
6.
Perry, Benjamin, et al.. (2022). NTD Drug Discovery Booster, Achievements and Next Steps. YAKUGAKU ZASSHI. 142(7). 685–689. 2 indexed citations
7.
Samby, Kirandeep, Anirban Dutta, Paul A. Glossop, et al.. (2022). The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease Outbreaks. ACS Infectious Diseases. 8(4). 713–720. 20 indexed citations
8.
Delft, F. von, Mark Calmiano, John D. Chodera, et al.. (2021). A white-knuckle ride of open COVID drug discovery. Nature. 594(7863). 330–332. 16 indexed citations
9.
Perry, Benjamin, Emmanuel Le Poul, Sonia Poli, et al.. (2013). A novel series of metabotropic glutamate receptor 5 negative allosteric modulators based on a 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine core. Bioorganic & Medicinal Chemistry Letters. 23(16). 4523–4527. 5 indexed citations
10.
Lütjens, Robert, Benjamin Perry, Dominik Schelshorn, & Jean‐Philippe Rocher. (2013). New technologies enabling the industrialization of allosteric modulator discovery. Drug Discovery Today Technologies. 10(2). e253–e260.
11.
Pitt, William R., David M. Parry, Benjamin Perry, & Colin R. Groom. (2009). Heteroaromatic Rings of the Future. Journal of Medicinal Chemistry. 52(9). 2952–2963. 263 indexed citations
12.
Phillips, David J., Richard Davenport, Mark Jones, et al.. (2008). Imidazopyridines as VLA-4 integrin antagonists. Bioorganic & Medicinal Chemistry Letters. 18(14). 4146–4149. 13 indexed citations
13.
Perry, Benjamin, Gavin Bennett, George M. Buckley, et al.. (2008). Optimization of a series of multi-isoform PI3 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(19). 5299–5302. 9 indexed citations
14.
Braddock, D. Christopher, et al.. (2004). Planar Chiral PHANOLs as Double Hydrogen Bonding Donor Organocatalysts: Synthesis and Catalysis. Advanced Synthesis & Catalysis. 346(9-10). 1117–1130. 37 indexed citations
15.
Braddock, D. Christopher, et al.. (2003). Planar Chiral PHANOLs as Organocatalysts for the Diels—Alder Reaction via Double Hydrogen‐Bonding to a Carbonyl Group.. ChemInform. 34(41). 2 indexed citations
16.
Braddock, D. Christopher, et al.. (2003). Planar Chiral PHANOLs as Organocatalystsfor the Diels-Alder Reaction via Double Hydrogen-Bondingto a Carbonyl Group. Synlett. 1121–1124. 26 indexed citations
17.
Braddock, D. Christopher, et al.. (2002). Improved Synthesis of (±)-4,12-Dihydroxy[2.2]paracyclophane and Its Enantiomeric Resolution by Enzymatic Methods:  Planar Chiral (R)- and (S)-Phanol. The Journal of Organic Chemistry. 67(24). 8679–8681. 59 indexed citations
18.
Braddock, D. Christopher, et al.. (2001). A curious benzenoid deacylation reaction: neighbouring group participation in acylhydroxy[2.2]paracyclophanes. Tetrahedron Letters. 42(42). 7527–7529. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Murugavel Breakdown of academic impact, for papers by Asier Gómez‐SanJuan Breakdown of academic impact, for papers by Leandro Cotos Breakdown of academic impact, for papers by Parameshwar Makam Breakdown of academic impact, for papers by Katja Ester Breakdown of academic impact, for papers by Gagan Kukreja Breakdown of academic impact, for papers by Guilherme R. Oliveira Breakdown of academic impact, for papers by Setshaba D. Khanye Breakdown of academic impact, for papers by Neelima Sinha Breakdown of academic impact, for papers by Jonathan Shearer
Rankless by CCL
2026